Zhejiang Shengyang Science (603703) — Capital Reinvestment Ratio
Latest as of September 2025:
1.96x
Zhejiang Shengyang Science (603703) has a Capital Reinvestment Ratio of 1.96x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥8.25 Million) in capital expenditures (CN¥16.20 Million). See 603703 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.96x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥8.25 Million
CNY
Capital Expenditures
CN¥16.20 Million
CNY
Data as of
Sep 2025
Most recent filing
Zhejiang Shengyang Science Capital Reinvestment Ratio (2012–2025)
This chart tracks Zhejiang Shengyang Science's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for Zhejiang Shengyang Science (2012–2025)
Year-by-year Capital Reinvestment Ratio for Zhejiang Shengyang Science from 2012 to 2025. For live market cap and broader valuation context, see Zhejiang Shengyang Science (603703) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.94x | CN¥39.15 Million | CN¥75.94 Million | ▲ +51.7% |
| 2023 | 1.28x | CN¥81.30 Million | CN¥103.97 Million | ▲ +11.4% |
| 2022 | 1.15x | CN¥89.94 Million | CN¥103.28 Million | ▼ -1.6% |
| 2021 | 1.17x | CN¥76.14 Million | CN¥88.88 Million | ▲ +29.7% |
| 2020 | 0.90x | CN¥55.06 Million | CN¥49.53 Million | ▲ +42.3% |
| 2019 | 0.63x | CN¥52.25 Million | CN¥33.04 Million | ▲ +35.2% |
| 2018 | 0.47x | CN¥62.76 Million | CN¥29.36 Million | ▲ +98.3% |
| 2017 | 0.24x | CN¥129.96 Million | CN¥30.65 Million | ▼ -62.1% |
| 2016 | 0.62x | CN¥33.70 Million | CN¥20.97 Million | ▼ -6.9% |
| 2014 | 0.67x | CN¥66.34 Million | CN¥44.34 Million | ▼ -26.1% |
| 2013 | 0.90x | CN¥48.66 Million | CN¥43.98 Million | ▼ -81.4% |
| 2012 | 4.86x | CN¥4.85 Million | CN¥23.56 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow